Tag: Tack endovascular system
Philips announces positive two-year data from TOBA II BTK clinical trial
Royal Philips recently announced positive two-year results from the TOBA (Tack optimised balloon angioplasty) II below-the-knee (BTK) clinical trial.
The data show the Philips...
TOBA III clinical trial results published in the Journal of Vascular...
Intact Vascular has announced the peer-reviewed publication of its Tack optimised balloon angioplasty (TOBA) III 12-month clinical trial results in the Journal of Vascular Surgery.
The multi-centre, single-arm,...
FDA grants premarket approval for Intact Vascular’s dissection repair device
The US Food and Drug Administration (FDA) have granted Intact Vascular pre-market approval application for an additional size of its Tack Endovascular System, a...
Tack Endovascular System launches in the EU with first commercial use...
The first commercial use of the Tack Endovascular System (Intact Vascular) has taken place in multiple hospitals within Germany. A novel therapy for dissection...
TOBA II trial meets primary and secondary endpoints at one-year
The Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial has successfully achieved both primary and secondary endpoints. One year results from the TOBA...
US FDA approves TOBA II BTK pivotal IDE clinical study
The US Food and Drug Administration (FDA) has granted staged approval for Intact Vascular’s investigational device exemption (IDE) application to begin its TOBA II...
